By autoradiography, neurotensin (NT) binding is specifically detectable in
pancreatic cancer, but not in the normal pancreas, chronic pancreatitis (CP
), or other pancreatic disorders. In the present study, we investigated whe
ther this is due to NT receptor-1 (NTR-1) mRNA up-regulation and whether NT
R-I mRNA could also be used as a specific diagnostic marker and treatment t
arget in pancreatic cancer.
Fifteen normal pancreas tissue samples, 20 CP samples, and 30 pancreatic ca
ncer samples were studied. Expression and localization of NTR-1 mRNA uas in
vestigated by Northern blot analysis and in situ hybridization. Furthermore
, consecutive tissue sections were analyzed for NTR-1 mRNA expression and N
T binding.
By Northern blot analysis, NTR-I mRNA expression was 4.4-fold (P < 0.01) an
d 3.0-fold (P < 0.01) higher in pancreatic cancer and CP tissue samples, re
spectively? compared with normal controls, There was no difference in NTR-1
mRNA levels between CP and cancer samples (P > 0.05), In pancreatic cancer
, the NTR-1 mRNA, levels were higher in advanced tumor stage (stages III an
d IV) than early tumor stage (stages I and II; P < 0.05), but no difference
was found between well moderately differentiated (grades 1 and 2) and poor
ly differentiated/undifferentiated cancers (grades 3 and 4; P > 0.05), By i
n situ hybridization, NTR-I mRNA signals were weakly present in the cytopla
sm of acinar and ductal cells of the normal pancreas, Moderate to intense N
TR-I mRNA signals were present in the cytoplasm of acinar cells dedifferent
iating into tubular complexes and degenerating acinar cells of CP samples.
In the cancer samples, NTR-1 mRNA was moderately to intensely expressed in
the cytoplasm of cancer cells. When on consecutive tissue sections NTR-1 mR
NA expression was compared with the presence of NTR-I, measured by receptor
autoradiography, a correlation was found in carcinomas but not in CP sampl
es, In which no receptors were detectable by autoradiography.
The enhanced expression of NTR-1 mRNA in pancreatic cancer cells further su
ggests that neuroendocrine hormones might modulate pancreas cancer cell beh
avior. However, its relatively high levels in CP excludes NTR-1 mRNA as a s
pecific parameter for pancreatic cancer and for the differentiation of panc
reatic cancer from CP.